Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)

Market Cap	151.95B
Revenue (ttm)	196.27B +1.2%
Net Income	8.53B +55.9%
EPS	315.00 +55.2%
Shares Out	26.94M
PE Ratio	17.90
Forward PE	n/a
Dividend	300.00 (5.31%)
Ex-Dividend Date	Dec 29, 2025

Volume	29,272
Average Volume	36,419
Open	5,660.00
Previous Close	5,650.00
Day's Range	5,600.00 - 5,780.00
52-Week Range	5,290.00 - 6,890.00
Beta	0.49
RSI	58.45
Earnings Date	Aug 13, 2026

About Kyung Dong Pharmaceutical

Kyung Dong Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals in South Korea. The company offers prescription medicines for liver therapy, antispasmodic, antidiabetic, antiviral, corticosteroid, androgen alopecia, muscle relaxant, antimigraine, vitamin, antifungal, endocrinal, cardiovascular and dysplidemia, urology, antibacterial, cardiovascular, pain/inflammation, smoking cessation aid, gastrointestinal, antihistamine, CNS, antiobesity, NVP, neuropathic, osteoporosis, respiratory, allergy, and arthrifuge categories. It also provi...

• Industry: Pharmaceutical Preparations
• Founded: 1975
• Employees: 350
• Stock Exchange: KOSDAQ
• Ticker Symbol: 011040

Financial Performance

In 2025, Kyung Dong Pharmaceutical's revenue was 196.27 billion, an increase of 1.20% compared to the previous year's 193.94 billion. Earnings were 8.53 billion, an increase of 55.93%.